Breast Cancer Research and Treatment

, Volume 116, Issue 1, pp 201–207

The economic burden of breast cancer in California

Epidemiology

Abstract

This paper estimates the healthcare costs and the value of lost productivity from premature deaths for California women with breast cancer in 2001, with an updated estimate for 2008. Multiple secondary data sources were used to estimate the healthcare cost of breast cancer. Mortality costs were estimated as the product of the number of deaths and the expected value of a woman’s future earnings. The total economic cost of breast cancer in California was $1.43 billion in 2001, or $1.91 billion in 2008 dollars. Breast cancer is costly both in terms of healthcare dollars and the value of lost lives. Regular screening and access to treatment for all women will allow the disease to be diagnosed earlier, the prognosis improved, and the economic burden reduced.

Keywords

Breast cancer Breast cancer costs Healthcare costs Costs-of-illness Direct and indirect costs 

References

  1. 1.
    American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2007) California cancer facts and figures 2008. American Cancer Society, California Division, Oakland, CAGoogle Scholar
  2. 2.
    Kwong SL, Perkins CI, Morris CR, Cohen R, Allen M, Wright WE (2001) Cancer in California: 1988–1999. California Department of Health Services, Cancer Surveillance Section, Sacramento, CAGoogle Scholar
  3. 3.
    American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2006) California cancer facts and figures 2007. American Cancer Society, California Division, Oakland, CAGoogle Scholar
  4. 4.
    Harris DH, Bates J, Morris CR, Kwong SL, Wright WE (2005) Female breast cancer in California, 2005. California Department of Health Services, Cancer Surveillance Section, Sacramento, CAGoogle Scholar
  5. 5.
    Yabroff KR, Warren JL, Brown ML (2007) Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol 4:643–656. doi:10.1038/ncponc0978 PubMedCrossRefGoogle Scholar
  6. 6.
    Rice D, Hodgson TA (1981) Social and economic implications of cancer in the United States, Vital and Health Statistics, Series 3, No. 20. DHHS Pub. No. (PHS) 81–1404. US Government Printing Office, Washington, DCGoogle Scholar
  7. 7.
    Hodgson TA, Rice DP (1982) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. W.B. Saunders Company, Philadelphia, PA, pp 208–228Google Scholar
  8. 8.
    Brown M, Fintor L (1995) The economic burden of cancer. In: Greenwald P, Kramer B, Weed D (eds) Cancer prevention and control. Marcel Dekker, New YorkGoogle Scholar
  9. 9.
    Barron JJ, Quimbo R, Nikam PT, Amonkar MM (2008) Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res Treat 109:367–377. doi:10.1007/s10549-007-9650-4 PubMedCrossRefGoogle Scholar
  10. 10.
    Rice D, Hodgson T, Capell F (1989) The economic burden of cancer, 1985: United States and California. In: Scheffler R, Andrews N (eds) Cancer care and costs: DRGs and beyond. Health Administration Press Perspectives, Ann Arbor, MichiganGoogle Scholar
  11. 11.
    Gabrel C, Jones A (2000) The National Nursing Home Survey: 1997 Summary. National Center for Health Statistics. Vital Health Stat 13, vol 147, pp 1–121Google Scholar
  12. 12.
    California Department of Health Services (CDHS) (2003) Abridged life tables for California, 2001. CDHS, Center for Health Statistics, Sacramento, CA. Available at http://www.dhs.ca.gov/chs/OHIR/reports/others/LifeTables2001.pdf. Accessed 30 October 2007
  13. 13.
    Max W, Rice DP, Michel M, Sung H-Y (2002) Calculating the present value of lifetime earnings 2000. Available at http://repositories.cdlib.org/ctcre/esarm/PVLE2000/. Accessed 14 March 2008
  14. 14.
    American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2000) California cancer facts and figures 2001. American Cancer Society, California Division, Oakland, CAGoogle Scholar
  15. 15.
    Max W, Rice DP, Sung H-Y, Michel M, Breuer W, Zhang X (2003) The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol 88:96–103. doi:10.1016/S0090-8258(02)00101-4 PubMedCrossRefGoogle Scholar
  16. 16.
    Max W, Rice DP, Sung H-Y, Michel M, Breuer W, Zhang X (2002) The economic burden of prostate cancer in California, 1998. Cancer 94(11):2906–2913. doi:10.1002/cncr.10532 PubMedCrossRefGoogle Scholar
  17. 17.
    US Census Bureau (2007) Statistical abstract of the United States: 2008 (127th edn). Washington, DC. Table 219Google Scholar
  18. 18.
    Yabroff KR, Davis WW, Lamont EB et al (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99:14–23PubMedCrossRefGoogle Scholar
  19. 19.
    Genentech Website Available at http://www.gene.com/gene/ir/financials/historical/herceptin.html. Accessed 23 June 2008
  20. 20.
    Fleck LM (2006) The costs of caring: Who pays? Who profits? Who panders? Hastings Cent Rep 36(3):13–17. doi:10.1353/hcr.2006.0040 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  1. 1.Institute for Health & Aging, School of NursingUniversity of California at San FranciscoSan FranciscoUSA

Personalised recommendations